Nonsteroidal antiiinflammatory drugs (NSAIDs) may be associated with an increased risk of adverse cardiovascular events in certain patients. The risk can be seen not only with selective inhibitors of cyclooxygenase-2, but also with other classes of NSAIDs as well.